Dr. David Spigel from Sarah Cannon Cancer Center offers his perspective on the agents he feels most likely to become clinical tools against lung cancer over the next few years.
[powerpress]
Logo
You are here
Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?
Related Content
Article
Published April 6, 2012 | By Dr West | 6 Comments
Article
Did you recently receive a diagnosis of non small cell lung cancer?
GRACE has partnered with Clinical Care Options to develop an interactive online tool to help you understand more about your disease and treatment options. Answer a series of multiple-choice questions and then get treatment options chosen by the 5 lung cancer experts listed below.